Impact of aging on treatment considerations for multiple sclerosis patients

With a rapidly aging global population and improvement of outcomes with newer multiple sclerosis (MS)-specific disease-modifying therapies (DMTs), the epidemiology of MS has shifted to an older than previously described population, with a peak prevalence of the disease seen in the 55–65 years age gr...

Szczegółowa specyfikacja

Opis bibliograficzny

Główni autorzy:	Gabrielle Macaron, Catherine Larochelle, Nathalie Arbour, Manon Galmard, Jean Marc Girard, Alexandre Prat, Pierre Duquette
Format:	Artigo
Język:	Inglês
Wydane:	Frontiers Media S.A. 2023-07-01
Seria:	Frontiers in Neurology
Hasła przedmiotowe:	multiple sclerosis (MS) aging comorbidity treatment efficacy and safety treatment discontinuation
Dostęp online:	https://www.frontiersin.org/articles/10.3389/fneur.2023.1197212/full
Etykiety:	Dodaj etykietę Nie ma etykietki, Dołącz pierwszą etykiete!